Jim Baker
Blueprint Medicines
Jim Baker serves as Senior Vice President of Corporate Affairs and a member of the executive team at Blueprint Medicines, a global biopharmaceutical company. He brings more than 15 years of experience as a biopharmaceutical communications leader building entrepreneurial, science-driven companies from discovery to commercialization, across global markets and through collaboration ecosystems. Since joining Blueprint Medicines in 2017, Jim has overseen investor relations, corporate communications, global patient affairs, and internal communications. During his tenure, Jim has played a key role in guiding the company’s evolution from an early development-stage enterprise to a fully integrated global biopharmaceutical company with two marketed medicines. He has helped the company raise more than $1.5 billion in capital, advanced pipeline strategy and programs as a member of the portfolio management team, and fostered and maintained a high-performance culture through periods of significant growth and change. Prior to joining Blueprint Medicines, Jim held roles of increasing responsibility in investor relations, corporate communications, new product planning and market development, and patient advocacy at Biogen, Sarepta Therapeutics, PTC Therapeutics, and Idera Pharmaceuticals. Jim received dual B.A. degrees in journalism and political science from the University of Southern California, where he was a Reserve Officer Training Corps scholar, and completed his military service as a Captain in the U.S. Army Signal Corps. He is a cancer survivor who is committed to helping other patients with cancer and their families live well.